| This article has been cited by |
| 1 | Implantable sensor for local Cherenkov-excited luminescence imaging of tumor pO2 during radiotherapy | |
| Xu Cao,Jason R. Gunn,Srinivasa Rao Allu,Petr Bruza,Shudong Jiang,Sergei A. Vinogradov,Brian W. Pogue |
| Journal of Biomedical Optics.2020;25(11) |
| [DOI] |
|
| 2 | Implantable sensor for local Cherenkov-excited luminescence imaging of tumor pO2 during radiotherapy | |
| Luisa Ottobrini,Cristina Martelli,Giovanni Lucignani |
| Journal of Biomedical Optics.2021;25(11)603 |
| [DOI] |
|
| 3 | Optical imaging probes in oncology | |
| Cristina Martelli,Alessia Lo Dico,Cecilia Diceglie,Giovanni Lucignani,Luisa Ottobrini |
| Oncotarget.2016;7(30)48753 |
| [DOI] |
|
| 4 | The Translational and Regulatory Development of an Implantable Microdevice for Multiple Drug Sensitivity Measurements in Cancer Patients | |
| Christine Dominas,Sharath Bhagavatula,Elizabeth Stover,Kyle Deans,Cecilia Larocca,Yolanda Colson,Pierpaolo Peruzzi,Adam Kibel,Nobuhiko Hata,Lillian Tsai,Yin Hung,Robert Packard,Oliver Jonas |
| IEEE Transactions on Biomedical Engineering.2022;69(1)412 |
| [DOI] |
|
| 5 | Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist | |
| Nader Sanai |
| Neurosurgery.2019;85(6)E967 |
| [DOI] |
|
| 6 | Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies | |
| Rajiv Mahajan,Kapil Gupta |
| Journal of Pharmacy And Bioallied Sciences.2010;2(4)307 |
| [DOI] |
|
| 7 | Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies | |
| David J. Donnelly, |
| Journal of Pharmacy And Bioallied Sciences.2020;2(4)703 |
| [DOI] |
|
| 8 | Can prospective systematic reviews of animal studies improve clinical translation? | |
| Pandora Pound,Merel Ritskes-Hoitinga |
| Journal of Translational Medicine.2020;18(1)703 |
| [DOI] |
|
| 9 | Phase zero trials: a novel approach in drug development process | |
| Neeraj Kumar Fuloria,Shivkanya Fuloria,Syed Vakiloddin |
| Renal Failure.2013;35(7)1044 |
| [DOI] |
|
| 10 | A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research | |
| Dorian M. Cheff,Matthew D. Hall |
| Journal of Medicinal Chemistry.2017;60(11)4517 |
| [DOI] |
|
| 11 | How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework | |
| Manon van den Berg,Igor Magaraggia,Rudy Schreiber,Todd M. Hillhouse,Joseph H. Porter |
| Psychopharmacology.2022;239(6)1853 |
| [DOI] |
|
| 12 | How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework | |
| Tal Burt,Robert D. Combes |
| Psychopharmacology.2019;239(6)229 |
| [DOI] |
|
| 13 | How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework | |
| Gunasakaran Sambandan,Adina Turcu-Stiolica |
| Psychopharmacology.2019;239(6)323 |
| [DOI] |
|
| 14 | First-in-human dose: current status review for better future perspectives | |
| Archana Mishra,Sudhir Chandra Sarangi,Kh Reeta |
| European Journal of Clinical Pharmacology.2020;76(9)1237 |
| [DOI] |
|
| 15 | Performing radiosynthesis in microvolumes to maximize molar activity of tracers for positron emission tomography | |
| Maxim Sergeev,Mark Lazari,Federica Morgia,Jeffrey Collins,Muhammad Rashed Javed,Olga Sergeeva,Jason Jones,Michael E. Phelps,Jason T. Lee,Pei Yuin Keng,R. Michael van Dam |
| Communications Chemistry.2018;1(1)1237 |
| [DOI] |
|
